FDA Fast-Tracks First Nasal Spray for Allergic Reactions, Anaphylaxis

The US Food and Drug Administration (FDA) recently approved neffy, an epinephrine nasal spray, to treat emergency allergic reactions, including anaphylaxis. The spray is the first alternative treatment to epinephrine injections for adults and children who weigh at least 30 kg, or about 66 lb.

Authors

Publication Details

Journal
JAMA
Published
2024-09-06
DOI
https://doi.org/10.1001/jama.2024.17605
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FDA Fast-Tracks First Nasal Spray for Allergic Reactions, Anaphylaxis

Samantha Anderer
JAMA
Allergic Rhinitis and Sensitization
article

FDA Fast-Tracks First Nasal Spray for Allergic Reactions, Anaphylaxis

Samantha Anderer
article en

Abstract

The US Food and Drug Administration (FDA) recently approved neffy, an epinephrine nasal spray, to treat emergency allergic reactions, including anaphylaxis. The spray is the first alternative treatment to epinephrine injections for adults and children who weigh at least 30 kg, or about 66 lb.

JAMAVol. 332(13)
Zero hunger
Openalex Percentile: Top 78%
Allergic Rhinitis and Sensitization
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FDA Fast-Tracks First Nasal Spray for Allergic Reactions, Anaphylaxis — Samantha Anderer · JAMA (2024) | TGRS Research Map | TGRS